Home LiteratureArticle Details
PMID: 1318370 Published · ppublish English Comparative Study Journal Article

Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies.

The Journal of pharmacology and experimental therapeutics ·Vol. 261 ·No. 3 ·1992-06-00 ·Pages 1106-12

Facklam M, Schoch P, Haefely WE

Abstract

Intrinsic efficacy is the inherent ability of a ligand to induce the conformational change of its receptor that is required to transduce the event of signal recognition into a physiologically relevant response. Relating fractional receptor occupancy to fractional effect is an indirect but reliable way to assess relative intrinsic efficacy. The receptor studied was the benzodiazepine receptor (BZR), a modulatory site on the gamma-aminobutyric acidA (GABAA) receptor-chloride channel. The relationship between fractional BZR occupancy, as assessed by inhibition of [3H]flumazenil binding, and potentiation of GABA-stimulated 36Cl- influx into membrane vesicles of rat cerebral cortex was evaluated for four ligands under identical experimental conditions. Triazolam and the quinolizinone Ro 19-8022 potentiated the effect of GABA maximally by nearly 50%, diazepam by about 40% and bretazenil by approximately 20%. Potentiation of GABA-stimulated 36Cl- flux by 25% was observed at about 35% BZR occupancy for diazepam, about 45% for triazolam and about 95% for Ro 19-8022. Bretazenil did not produce 25% potentiation even at receptor saturation. Although the curves relating fractional BZR occupancy to GABA potentiation were hyperbolic and nearly superimposable for triazolam and diazepam, those for Ro 19-8022 and bretazenil displayed parabolic characteristics by inducing an effect only at very high BZR occupancy, reflecting the partial agonistic profile of the latter two compounds. The rank order of relative intrinsic efficacy determined in this study was: triazolam congruent to diazepam much greater than Ro 19-8022 greater than bretazenil.

MeSH Terms
Animals Benzodiazepinones/pharmacology Cell Membrane/drug effects Cerebral Cortex/drug effects,metabolism Chlorides/metabolism Diazepam/pharmacology Drug Synergism Flumazenil/metabolism Ligands Male Rats Receptors, GABA-A/drug effects,metabolism Triazolam/pharmacology gamma-Aminobutyric Acid/pharmacology
Chemicals
Benzodiazepinones Chlorides Ligands Receptors, GABA-A Triazolam Flumazenil gamma-Aminobutyric Acid bretazenil Diazepam
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Facklam M
Pharma Division-Preclinical Research, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Schoch P
Haefely W E
Article Info
Journal
The Journal of pharmacology and experimental therapeutics
Abbr.
J Pharmacol Exp Ther
ISSN
0022-3565
Published
1992-06-00
Pages
1106-12
Language
English
Region
United States
NLM ID
0376362
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com